NP

Neelam Pundir

Active Director Director DIN 09265118
DIN 09265118 First appointment Aug 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Neelam Pundir

Data last updated:

Neelam Pundir is a Director at Unitek Healthcare And Lifesciences Private Limited (since 2021). The company operates in Trading. Unitek Healthcare And Lifesciences Private Limited reported revenue of ₹7,161 (FY 2025).

DIN 09265118
Primary Designation Director
Industry Trading
First Appointment 03 Aug 2021
Oldest Company Age 5 yrs
Largest company Unitek Healthcare And Lifesciences Private Limited · ₹7,161 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Aug 20212021₹7,161 (FY 2025)Active

Board colleagues of Neelam Pundir

Directorship timeline

Open interactive timeline →
Unitek Healthcare And Lifesciences Private Limited
Premium access

Shareholding and investment profile for Neelam Pundir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Pundir

Neelam Pundir currently holds 1 directorship: Unitek Healthcare And Lifesciences Private Limited (Director, since 03 Aug 2021, revenue ₹7,161 (FY 2025)).

Neelam Pundir was first appointed on 03 Aug 2021 as Director at Unitek Healthcare And Lifesciences Private Limited.

The current boards of Neelam Pundir's companies include Sandeep Pundir (Unitek Healthcare And Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available